Susquehanna International Group, LLP Oramed Pharmaceuticals Inc. Transaction History

Susquehanna International Group, LLP

$823 Billion
Q3 2025

A detailed history of Susquehanna International Group, LLP transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 36,825 shares of ORMP stock, worth $87,643. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,825

Previous 48,428 23.96%

Holding current value

$87,643

Previous $108,000 12.04%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$2.06 - $2.7 $23,902 - $31,328	-11,603 Reduced 23.96%	36,825 $95,000
Q2 2025 Aug 14, 2025	SELL	$2.03 - $2.38 $105,089 - $123,207	-51,768 Reduced 51.67%	48,428 $108,000
Q1 2025 May 14, 2025	BUY	$2.0 - $2.62 $18,338 - $24,022	9,169 Added 10.07%	100,196 $214,000
Q4 2024 Feb 14, 2025	SELL	$2.17 - $2.52 $94,060 - $109,231	-43,346 Reduced 32.26%	91,027 $220,000
Q3 2024 Nov 14, 2024	BUY	$2.21 - $2.63 $18,884 - $22,473	8,545 Added 6.79%	134,373 $327,000

Q2 2024 Aug 15, 2024	SELL	$2.07 - $2.83 $452,522 - $618,666	-218,610 Reduced 63.47%	125,828 $323,000
Q1 2024 May 07, 2024	BUY	$2.18 - $3.58 $650,777 - $1.07 Million	298,522 Added 650.15%	344,438 $1.01 Million
Q4 2023 Feb 14, 2024	BUY	$1.71 - $2.57 $56,170 - $84,419	32,848 Added 251.36%	45,916 $106,000
Q3 2023 Nov 14, 2023	SELL	$2.51 - $3.55 $186,831 - $264,244	-74,435 Reduced 85.07%	13,068 $34,000
Q2 2023 Aug 11, 2023	BUY	$2.12 - $4.47 $155,425 - $327,713	73,314 Added 516.7%	87,503 $313,000
Q1 2023 May 16, 2023	SELL	$1.93 - $13.1 $330,834 - $2.25 Million	-171,417 Reduced 92.36%	14,189 $30,000
Q4 2022 Feb 14, 2023	BUY	$5.88 - $12.03 $83,901 - $171,656	14,269 Added 8.33%	185,606 $2.23 Million
Q3 2022 Nov 14, 2022	BUY	$4.6 - $9.91 $297,615 - $641,167	64,699 Added 60.67%	171,337 $1.11 Million
Q2 2022 Aug 15, 2022	BUY	$3.72 - $9.0 $106,589 - $257,877	28,653 Added 36.74%	106,638 $488,000
Q1 2022 May 16, 2022	SELL	$8.19 - $13.89 $314,684 - $533,695	-38,423 Reduced 33.01%	77,985 $675,000
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $1.3 Million - $2.97 Million	99,976 Added 608.42%	116,408 $1.66 Million
Q3 2021 Nov 15, 2021	BUY	$12.13 - $23.82 $53,735 - $105,522	4,430 Added 36.91%	16,432 $361,000
Q2 2021 Aug 11, 2021	SELL	$8.34 - $14.59 $469,567 - $821,460	-56,303 Reduced 82.43%	12,002 $161,000
Q1 2021 May 17, 2021	BUY	$4.22 - $11.33 $230,736 - $619,490	54,677 Added 401.21%	68,305 $694,000
Q4 2019 Feb 14, 2020	SELL	$2.43 - $5.74 $2,857 - $6,750	-1,176 Reduced 7.94%	13,628 $70,000
Q3 2019 Nov 14, 2019	BUY	$2.88 - $3.96 $42,635 - $58,623	14,804 New	14,804 $47,000
Q1 2018 May 15, 2018	SELL	$6.51 - $9.14 $120,265 - $168,852	-18,474 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$7.95 - $11.15 $2,289 - $3,211	-288 Reduced 1.54%	18,474 $166,000
Q3 2017 Nov 14, 2017	BUY	$7.74 - $10.78 $145,217 - $202,254	18,762	18,762 $185,000

Others Institutions Holding ORMP

# of Institutions

Shares Held

7.66M

Call Options Held

Put Options Held

View Full List

About ORAMED PHARMACEUTICALS INC.

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92.4M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

More about ORMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Oramed Pharmaceuticals Inc. Transaction History